Functional inhibition of acid sphingomyelinase disrupts infection by intracellular bacterial pathogens

dc.contributor.authorCockburn, Chelsea L.
dc.contributor.authorGreen, Ryan S.
dc.contributor.authorDamle, Sheela R.
dc.contributor.authorMartin, Rebecca K.
dc.contributor.authorGhahrai, Naomi N.
dc.contributor.authorColonne, Punsiri M.
dc.contributor.authorFullerton, Marissa S.
dc.contributor.authorConrad, Daniel H.
dc.contributor.authorChalfant, Charles E.
dc.contributor.authorVoth, Daniel E.
dc.contributor.authorRucks, Elizabeth A.
dc.contributor.authorGilk, Stacey D.
dc.contributor.authorCarlyon, Jason A.
dc.contributor.departmentDepartment of Microbiology and Immunology, Indiana University School of Medicineen_US
dc.date.accessioned2019-09-17T20:33:08Z
dc.date.available2019-09-17T20:33:08Z
dc.date.issued2019-03-22
dc.description.abstractIntracellular bacteria that live in host cell-derived vacuoles are significant causes of human disease. Parasitism of low-density lipoprotein (LDL) cholesterol is essential for many vacuole-adapted bacteria. Acid sphingomyelinase (ASM) influences LDL cholesterol egress from the lysosome. Using functional inhibitors of ASM (FIASMAs), we show that ASM activity is key for infection cycles of vacuole-adapted bacteria that target cholesterol trafficking-Anaplasma phagocytophilum, Coxiella burnetii, Chlamydia trachomatis, and Chlamydia pneumoniae. Vacuole maturation, replication, and infectious progeny generation by A. phagocytophilum, which exclusively hijacks LDL cholesterol, are halted and C. burnetii, for which lysosomal cholesterol accumulation is bactericidal, is killed by FIASMAs. Infection cycles of Chlamydiae, which hijack LDL cholesterol and other lipid sources, are suppressed but less so than A. phagocytophilum or C. burnetii A. phagocytophilum fails to productively infect ASM-/- or FIASMA-treated mice. These findings establish the importance of ASM for infection by intracellular bacteria and identify FIASMAs as potential host-directed therapies for diseases caused by pathogens that manipulate LDL cholesterol.en_US
dc.eprint.versionFinal published versionen_US
dc.identifier.citationCockburn, C. L., Green, R. S., Damle, S. R., Martin, R. K., Ghahrai, N. N., Colonne, P. M., … Carlyon, J. A. (2019). Functional inhibition of acid sphingomyelinase disrupts infection by intracellular bacterial pathogens. Life science alliance, 2(2), e201800292. doi:10.26508/lsa.201800292en_US
dc.identifier.urihttps://hdl.handle.net/1805/20935
dc.language.isoen_USen_US
dc.publisherLife Science Allianceen_US
dc.relation.isversionof10.26508/lsa.201800292en_US
dc.relation.journalLife Science Allianceen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.sourcePMCen_US
dc.subjectIntracellular bacteriaen_US
dc.subjectHost cell–derived vacuolesen_US
dc.subjectAcid sphingomyelinaseen_US
dc.subjectInfection cyclesen_US
dc.subjectStatistical analysesen_US
dc.subjectLDL cholesterolen_US
dc.subjectHuman diseaseen_US
dc.titleFunctional inhibition of acid sphingomyelinase disrupts infection by intracellular bacterial pathogensen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
LSA-2018-00292.pdf
Size:
2.95 MB
Format:
Adobe Portable Document Format
Description:
Main article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: